Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Detalles Bibliográficos
Autores principales: Küçükyurt, Selin, Kelezoğlu, Alihan, Elverdi, Tuğrul, Özmen, Deniz, Ar, Muhlis Cem, Eşkazan, Ahmet Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244240/
https://www.ncbi.nlm.nih.gov/pubmed/34210618
http://dx.doi.org/10.1016/j.htct.2021.04.007
_version_ 1785054592886636544
author Küçükyurt, Selin
Kelezoğlu, Alihan
Elverdi, Tuğrul
Özmen, Deniz
Ar, Muhlis Cem
Eşkazan, Ahmet Emre
author_facet Küçükyurt, Selin
Kelezoğlu, Alihan
Elverdi, Tuğrul
Özmen, Deniz
Ar, Muhlis Cem
Eşkazan, Ahmet Emre
author_sort Küçükyurt, Selin
collection PubMed
description
format Online
Article
Text
id pubmed-10244240
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-102442402023-06-08 Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis Küçükyurt, Selin Kelezoğlu, Alihan Elverdi, Tuğrul Özmen, Deniz Ar, Muhlis Cem Eşkazan, Ahmet Emre Hematol Transfus Cell Ther Case Report Sociedade Brasileira de Hematologia e Hemoterapia 2023 2021-06-16 /pmc/articles/PMC10244240/ /pubmed/34210618 http://dx.doi.org/10.1016/j.htct.2021.04.007 Text en © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Küçükyurt, Selin
Kelezoğlu, Alihan
Elverdi, Tuğrul
Özmen, Deniz
Ar, Muhlis Cem
Eşkazan, Ahmet Emre
Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
title Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
title_full Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
title_fullStr Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
title_full_unstemmed Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
title_short Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
title_sort ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244240/
https://www.ncbi.nlm.nih.gov/pubmed/34210618
http://dx.doi.org/10.1016/j.htct.2021.04.007
work_keys_str_mv AT kucukyurtselin ponatinibbothasaneffectivebridgetoallogeneichematopoieticstemcelltransplantationandasposttransplantmaintenancetherapyinachronicmyeloidleukemiapatientwithmyeloidblastcrisis
AT kelezoglualihan ponatinibbothasaneffectivebridgetoallogeneichematopoieticstemcelltransplantationandasposttransplantmaintenancetherapyinachronicmyeloidleukemiapatientwithmyeloidblastcrisis
AT elverditugrul ponatinibbothasaneffectivebridgetoallogeneichematopoieticstemcelltransplantationandasposttransplantmaintenancetherapyinachronicmyeloidleukemiapatientwithmyeloidblastcrisis
AT ozmendeniz ponatinibbothasaneffectivebridgetoallogeneichematopoieticstemcelltransplantationandasposttransplantmaintenancetherapyinachronicmyeloidleukemiapatientwithmyeloidblastcrisis
AT armuhliscem ponatinibbothasaneffectivebridgetoallogeneichematopoieticstemcelltransplantationandasposttransplantmaintenancetherapyinachronicmyeloidleukemiapatientwithmyeloidblastcrisis
AT eskazanahmetemre ponatinibbothasaneffectivebridgetoallogeneichematopoieticstemcelltransplantationandasposttransplantmaintenancetherapyinachronicmyeloidleukemiapatientwithmyeloidblastcrisis

Ejemplares similares